Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Ryan A Metcalf; Claudia S Cohn; Sara Bakhtary; Thomas Gniadek; Gaurav Gupta; Sarah Harm; Richard L Haspel; Aaron S Hess; Jessica Jacobson; Parvez M Lokhandwala; Colin Murphy; Jacqueline N Poston; Micah T Prochaska; Jay S Raval; Nabiha H Saifee; Eric Salazar; Hua Shan; Nicole D Zantek; Monica B Pagano

doi:10.1111/trf.17475

Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion. 2023 Aug;63(8):1590-1600. doi: 10.1111/trf.17475. Epub 2023 Jul 5.

Authors

Ryan A Metcalf¹, Claudia S Cohn², Sara Bakhtary³, Thomas Gniadek⁴, Gaurav Gupta⁵, Sarah Harm⁶, Richard L Haspel⁷, Aaron S Hess⁸, Jessica Jacobson⁹, Parvez M Lokhandwala¹⁰, Colin Murphy¹¹, Jacqueline N Poston^{6

12}, Micah T Prochaska¹³, Jay S Raval¹⁴, Nabiha H Saifee¹⁵, Eric Salazar¹⁶, Hua Shan¹⁷, Nicole D Zantek², Monica B Pagano¹⁸

Affiliations

¹ Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
² Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
³ Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
⁴ Fresenius Kabi, Lake Zurich, Illinois, USA.
⁵ Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
⁶ Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, USA.
⁷ Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
⁸ Departments of Anesthesiology and Pathology & Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
⁹ Department of Pathology, NYU Grossman School of Medicine, New York, New York, USA.
¹⁰ Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
¹¹ TriCore Reference Laboratories, Albuquerque, New Mexico, USA.
¹² Department of Medicine, University of Vermont, Burlington, Vermont, USA.
¹³ Department of Medicine, University of Chicago, Chicago, Illinois, USA.
¹⁴ Department of Pathology, University of New Mexico, Albuquerque, New Mexico, USA.
¹⁵ Seattle Children's Hospital, Seattle, Washington, USA.
¹⁶ Department of Pathology, UT Health San Antonio, San Antonio, Texas, USA.
¹⁷ Department of Pathology, Stanford University, Palo Alto, California, USA.
¹⁸ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

PMID: 37403547
DOI: 10.1111/trf.17475

Abstract

Background: The Association for the Advancement of Blood and Biotherapies Clinical Transfusion Medicine Committee (CTMC) composes a summary of new and important advances in transfusion medicine (TM) on an annual basis. Since 2018, this has been assembled into a manuscript and published in Transfusion.

Study design and methods: CTMC members selected original manuscripts relevant to TM that were published electronically and/or in print during calendar year 2022. Papers were selected based on perceived importance and/or originality. References for selected papers were made available to CTMC members to provide feedback. Members were also encouraged to identify papers that may have been omitted initially. They then worked in groups of two to three to write a summary for each new publication within their broader topic. Each topic summary was then reviewed and edited by two separate committee members. The final manuscript was assembled by the first and senior authors. While this review is extensive, it is not a systematic review and some publications considered important by readers may have been excluded.

Results: For calendar year 2022, summaries of key publications were assembled for the following broader topics within TM: blood component therapy; infectious diseases, blood donor testing, and collections; patient blood management; immunohematology and genomics; hemostasis; hemoglobinopathies; apheresis and cell therapy; pediatrics; and health care disparities, diversity, equity, and inclusion.

Discussion: This Committee Report reviews and summarizes important publications and advances in TM published during calendar year 2022, and maybe a useful educational tool.